Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1454-1462, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1454-1462.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Interleukin-12 Promotes Pathologic Liver Changes
and Death in Mice Coinfected with Schistosoma mansoni and
Toxoplasma gondii
Maria Ilma
Araujo,1,2
Susan K.
Bliss,1
Yasuhiro
Suzuki,3
Ana
Alcaraz,4
Eric Y.
Denkers,1,* and
Edward J.
Pearce1
Department of Microbiology and
Immunology1 and New York State
Diagnostic Laboratory,4 College of Veterinary
Medicine, Cornell University, Ithaca, New York 14853; Servico
de Imunologia, Hospital Universitario Prof. Edgard Santos, Universidade
Federal da Bahia, Bahia, Brazil2; and
Department of Immunology and Infectious Diseases, Research
Institute, Palo Alto Medical Foundation, and Division of Infectious
Diseases and Geographic Medicine, Department of Medicine, Stanford
University School of Medicine, Palo Alto, California
493013
Received 22 August 2000/Returned for modification 11 October
2000/Accepted 30 November 2000
 |
ABSTRACT |
We previously demonstrated that mice concurrently infected with
Schistosoma mansoni and Toxoplasma gondii
undergo accelerated mortality which is preceded by severe liver damage.
Abnormally high levels of serum tumor necrosis factor alpha (TNF-
)
in the dually infected mice suggested a role for this and related
proinflammatory mediators in the pathologic alterations. In order to
evaluate the factors involved in increased inflammatory-mediator
production and mortality, interleukin-12
/
(IL-12
/
) mice were coinfected with S. mansoni and T. gondii, and survival and immune
responses were monitored. These IL-12
/
mice displayed
decreased liver damage and prolonged time to death relative to
wild-type animals also coinfected with these parasites. Relative to the
response of cells from the coinfected wild-type animals, levels of
TNF-
, gamma interferon, and NO produced by splenocytes from
coinfected IL-12
/
mice were reduced, and levels of IL-5
and IL-10 were increased, with the net result that the immune response
of the dually infected IL-12
/
mice was similar to that
of the wild-type mice infected with S. mansoni alone. While
dually infected wild-type animals succumb in the absence of overt
parasitemia, the delayed death in the absence of IL-12 is associated
with relatively uncontrolled T. gondii replication. These
data support the view that S. mansoni-infected mice are
acutely sensitive to infection with T. gondii as a result of their increased hepatic sensitivity to high levels of
proinflammatory cytokines; IL-12 and TNF-
are implicated in this process.
 |
INTRODUCTION |
Type 1 inflammatory and type 2 anti-inflammatory cytokine responses form the basis in large part for
understanding how the immune system responds to infection. It is now
well established that these contrasting cytokine responses display
cross-regulatory activity (1, 25, 30). For example, gamma
interferon (IFN-
) inhibits proliferation of Th2 cells, as well as
increasing Th1 activity by promoting interleukin-12 (IL-12) production
and maintaining IL-12R
2 expression on Th cells (26,
38). Conversely, IL-4 displays anti-inflammatory activity by
inhibiting macrophage activation and inhibits IFN-
production by
down-regulating IL-12R
2 expression (18, 36). IL-4 also
acts as an autocrine growth factor for Th2 T lymphocytes. For these
reasons, the immune system tends to polarize towards either
inflammatory or anti-inflammatory responses during infection. This is
exemplified by immunity to Toxoplasma gondii and
Schistosoma mansoni, respectively.
Schistosomiasis is a highly prevalent chronic parasitic infection that
affects 200 million people in developing countries. While in its
infectious stages, the parasite enters the host through the skin and
eventually locates to the mesenteric veins, where worm pairs deposit
hundreds to thousands of eggs per day. The eggs may cross into the
lumen of the intestine to exit the host, or they may be carried by the
circulatory system via the portal vein into the liver. Immunologically,
Schistosoma mansoni infection (Schistosomiasis) is notable
for the strong Th2 response of humans and experimental animals and for
the role of this response in host survival, as well as its role in
mediating the granulomatous immunopathology that is a hallmark of the
disease (3, 8, 27, 31, 37).
T. gondii is an opportunistic protozoan parasite with
worldwide distribution. Infection with T. gondii is usually
initiated when humans or other hosts eat undercooked meat containing
cysts from an infected animal or ingest water or food contaminated with oocysts shed in the feces of infected cats. Control of infection is
mediated by a strong inflammatory response, in which IL-12-dependent IFN-
plays a central and crucial role (2, 10, 15, 34). Infection normally proceeds from an acute phase associated with rapid
tachyzoite proliferation to a chronic stage characterized by the
presence of quiescent cysts within the central nervous system and
skeletal muscles. Nevertheless, mice orally infected with T. gondii develop an intestinal inflammatory response that, in
certain strains typified by C57BL/6, can be severe and
life-threatening. Intestinal disease in these animals is mediated in
part by a strong Th1 response, with the associated production of high
levels of IFN-
, tumor necrosis factor alpha (TNF-
), and NO
(21, 22). Thus, while these cytokines are crucial for the
full expression of immune effector mechanisms that limit the growth and
spread of T. gondii, the same cytokines can be detrimental
when overproduced in the absence of appropriate regulatory mediators
(16, 22, 29).
We recently became interested in determining how the immune system
responds when the host is coinfected with these two contrasting parasites. Our approach was to infect mice percutaneously with S. mansoni and then 7 weeks later to orally administer T. gondii cysts (23). Deposition of eggs is the major
type 2 cytokine stimulus during S. mansoni infection
(17, 31) and begins at week 5 postinfection, resulting in
a peak Th2 response by weeks 7 to 8. Hence, our protocol was designed
to evaluate the ability of the host to respond to a strong type-1
cytokine-inducing pathogen under the influence of an ongoing type-2
immune response to an unrelated parasite.
Our initial prediction was that an S. mansoni-induced type-2
cytokine response would ameliorate type-1 cytokine inflammation induced
during oral T. gondii infection (23). While
this proved to be the case, the animals nevertheless displayed
increased mortality and morbidity when infected with the two parasites.
Further examination revealed that the double-infected mice developed
severe liver damage marked by large areas of tissue destruction and the
presence of apoptotic hepatocytes. Associated with these pathologic
changes, serum TNF-
levels in double-infected mice were highly
elevated, leading us to hypothesize that this cytokine was involved in
mediating damage to the liver. Notably, our results revealed
alterations that could not be predicted based on previous studies on
animals infected with either T. gondii or S. mansoni alone.
Our goal is to understand the immunological basis of the pathologic
changes that develop in wild-type (WT) C57BL/6 mice coinfected with
T. gondii and S. mansoni. Since our previous work
implicated proinflammatory mediators in the development of the severe
disease associated with dual infection, we used IL-12
/
mice to determine whether T. gondii-induced IL-12 plays a
role in liver damage and early mortality in dually infected animals. IL-12 is a key initiator cytokine in the T. gondii-induced
inflammatory cascade (14, 15). Our results suggest that,
compared to WT mice, IL-12
/
mice display lower
production of TNF-
, IFN-
, and NO; decreased liver changes; and
prolonged survival time during double infection. The studies also
suggest that T. gondii infection suppresses the S. mansoni-induced Th2 response in an IL-12-dependent manner.
 |
MATERIALS AND METHODS |
Mice.
Female strain C57BL/6 (B6) mice were obtained from
Taconic Farms (Germantown, N.Y.) and Swiss-Webster B6 IL-12
p35
/
and B6 TNFRp55
/
female mice were
obtained from the Jackson Laboratory (Bar Harbor, ME). The animals were
kept under specific-pathogen-free conditions in the animal facility at
the College of Veterinary Medicine, Cornell University, Ithaca, N.Y.,
and used when they reached 8 to 10 weeks of age. For treatment with
aminoguanidine, an inhibitor of NO synthase with a selective preference
for inducible NO synthase, aminoguanidine hemisulfate (100 mM; Sigma,
St. Louis, Mo.) was provided in the sole source of drinking water
(7). Experimental groups consisted of five mice for
survival studies and three mice for immunological assessments. Each
experiment was performed at least twice.
Parasites and infections.
Mice were percutaneously infected
with 70 S. mansoni cercariae (NMRI strain) as previously
described (8). The ME49 T. gondii strain was
maintained by intraperitoneal inoculation of Swiss-Webster mice with
brain homogenate from mice that had been infected with T. gondii 6 to 8 weeks earlier. For B6 infection, brain homogenate of
T. gondii-infected mice was obtained and adjusted to 400 cysts/ml, and 250 µl of this suspension was administrated by gavage
to ether-anesthetized mice to give a final dose of 100 cysts/mouse. For
coinfection studies, the mice were infected with T. gondii 7 weeks after S. mansoni infection. On day 8 after T. gondii infection, mice were euthanized with CO2, their
spleens were removed for cell culture, and their livers were removed
for reverse transcription (RT)-PCR and histopathology and
immunohistochemistry analyses. In some experiments, blood was collected
by cardiac puncture into EDTA-containing tubes and centrifuged
(12,800 × g for 5 min), and the resulting plasma was
stored at
70°C for cytokine measurements.
Histopathological analysis.
Livers were removed from
experimental animals and immediately fixed in 10% (wt/vol) buffered
formaldehyde. Samples were then embedded in paraffin wax, cut into
6-µm sections, and stained with hematoxylin and eosin prior to
microscopic examination.
Cell culture.
Spleens from three mice per group were pooled.
Single cell suspensions were obtained by forcing tissues through
sterile 70-µm nylon mesh (Becton Dickinson) followed by extensive
washing with Dulbecco's modified eagle medium (Sigma). Erythrocytes
were removed by hypotonic lysis, and the remaining cells were
resuspended in complete tissue culture medium (composed of Dulbecco's
modified Eagle medium, 10% fetal calf serum, 25 mM HEPES, 5 × 10
5 M
-2-mercaptoethanol, 100 U of penicillin per ml,
100 µg of streptomycin per ml, and 2 mM glutamine, all from Sigma).
Cells were counted, adjusted to 107 per ml, and cultured
for 72 h at 37°C and 5% CO2 in flat-bottom 24-well
plates (Falcon) in complete tissue culture medium alone, with 20 µg
of soluble egg antigen (SEA) (5, 6) per ml, 20 µg of
soluble tachyzoite antigen (STAg) per ml (4), or with plate-bound MAb anti-CD3 (0.5 µg per well). After 72 h,
supernatants were recovered and assayed for cytokines and NO.
Cytokine ELISA.
Culture supernatant and/or plasma cytokine
levels of IFN-
, TNF-
, IL-4, IL-5, and IL-10 were measured by
two-site enzyme-linked immunosorbent assay (ELISA) using MAbs
commercially available from Pharmingen or R&D. Standard curves were
generated using recombinant cytokines, and absorbances were measured on
a microplate reader (Bio-Rad).
Nitric oxide production.
Levels of NO were measured using
the Greiss reaction as described elsewhere (24).
Plasma transaminase assay.
Presence of the liver-associated
enzyme aspartate transaminase (AST) in plasma was measured as
previously described (24). Briefly, 20 µl of plasma was
added to 100 µl of 0.2 M DL-aspartate and 1.8 mM
-ketoglutaric acid in phosphate-buffered saline (pH 7.5). The
solution was mixed and incubated at 37°C for 1 h, and then 100 µl of 2,4-diphenylhydrazine was added, and the mixture was incubated
for 20 min at room temperature. The reaction was stopped with 1 ml of
0.4 N NaOH, and sample absorbances were measured at 490 nm.
RT-PCR-mediated gene transcript amplification.
T.
gondii tachyzoite levels in the liver were evaluated by
RT-PCR-mediated amplification of transcripts for the parasite surface protein SAG-2 (p22). RNA was isolated and reverse transcribed with
3'-specific primers, and SAG-2, as well as hypoxanthine
phosphoribosyltransferase cDNA, was amplifed exactly as described
previously (23). The PCR products were resolved by
electrophoresis in a 2% agarose gel, and visualization of the DNA
bands was accomplished by staining with ethidium bromide and
illumination under a UV light box. Photographs of gels were scanned and
analyzed with the use of Adobe Photoshop software (Adobe Systems,
Mountain View, Calif.). Integrated band size and pixel density were
evaluated and expressed as a ratio of p22 band intensity divided by
hypoxanthine phosphoribosyltransferase band intensity.
Immunohistochemistry.
Immunoperoxidase staining with
polyclonal rabbit antibodies against T. gondii was used for
detection of the parasites (35). The total number of
parasitophorous vacuoles in 10 randomly selected fields per slide was counted.
Statistical analyses.
Differences in cytokine production in
plasma between IL-12
/
and WT coinfected mice as well as
differences in parasite burdens and AST levels were determined by
Student's t test. Differences in survival were determined
using the nonparametric Wilcoxon test. Probability values of
0.05
were considered significant.
 |
RESULTS |
IL-12 plays a role in promoting liver damage in mice coinfected
with S. mansoni and T. gondii.
As reported
previously (23), in WT dually infected mice, the hepatic
parenchyma had large areas of coalescing coagulative necrosis, marked
hepatic cord dissociation, and moderate cytoplasmic vacuolation (Fig.
1C and E). Strikingly, in dually infected
IL-12
/
mice, the hepatic parenchyma and architecture
were essentially preserved with minimal hepatocyte vacuolation (Fig. 1D
and F). The hepatic lesions in WT and IL-12
/
mice
infected with T. gondii were characterized by similar small inflammatory foci scattered throughout the parenchyma (Fig. 1A and B).
Consistent with our previous report (23), in WT mice, granulomas around schistosome eggs in dually infected animals appeared
smaller (20% of reduction) relative to those in animals infected with
S. mansoni alone; this size difference was less apparent in
dually infected IL-12
/
mice, whose granulomas were only
10% smaller than those in single-organism-infected animals (data not
shown). Hepatic changes were not observed in control uninfected mice.

View larger version (203K):
[in this window]
[in a new window]
|
FIG. 1.
Liver histopathology in WT and IL-12 /
mice infected with T. gondii (Tg) or S. mansoni
(Sm) plus T. gondii. (A and B) Liver samples from T. gondii-infected WT (A) and IL-12 / (B) mice; arrows
point to inflammatory foci. (C through F) Liver samples from coinfected
WT (C and E) and IL-12 / (D and F)
mice. Original magnifications, ×100 (A through D) and ×200 (E through
F). In WT dually infected mice (C and E), the hepatic parenchyma
displays areas of severe coagulative necrosis (lower arrows) and
cytoplasmic vacuolization (upper arrows), while in
IL-12 / dually infected mice (D and F), the hepatic
parenchyma and architecture are essentially preserved with minimal
cytoplasmic vacuolization.
|
|
Plasma levels of the liver-associated enzyme AST were measured in WT
and IL-12
/
mice infected with S. mansoni, T. gondii, or S. mansoni plus T. gondii (Fig.
2). AST is normally contained within
hepatocytes, but when the liver is damaged, AST is released, resulting
in elevated levels of the enzyme in the blood. Consistent with the
histopathological findings, levels of plasma AST were reduced in
double-infected IL-12
/
mice relative to coinfected WT
animals (P < 0.005).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Plasma levels of the liver-associated enzyme AST. AST
levels were measured in plasma taken from WT and IL-12 /
mice at 8 days post-T. gondii infection. The results are
expressed as means ± SD from three individual mice per group and
are representative of two separate experiments (SD < 1.0 where
error bar not visible). The difference in AST levels between WT and
IL-12 / coinfected mice was significant (P < 0.005). Levels of AST in control plasma (Control) from uninfected
mice were below 10 U/ml.
|
|
Production of inflammatory mediators is defective in
IL-12
/
animals.
Since excessive
inflammatory-mediator production is implicated in the severe liver
disease observed in mice infected with S. mansoni plus
T. gondii (23), we determined whether
reduced liver disease in dually infected IL-12
/
animals
was correlated with a diminished inflammatory-mediator response. To
examine splenocyte cytokine production, cells from single- and
double-infected IL-12
/
and WT mice were cultured in
vitro with media, SEA, STAg, or anti-CD3 MAb. Cells from T. gondii-infected WT mice produced TNF-
(Fig.
3A), IFN-
(Fig. 3D), and NO (Fig. 3G)
without further restimulation in vitro. The addition of antigen had a
minimal affect, but polyclonal stimulation with anti-CD3 significantly
increased levels of TNF-
and IFN-
. In comparison, under all in
vitro culture conditions, production of all three mediators by spleen
cells from T. gondii-infected IL-12
/
mice
was significantly lower than was the case for WT mice. These data
demonstrate the pivotal role of IL-12 in promoting inflammatory responses during infection with T. gondii. As expected,
cells from S. mansoni-infected mice made low or unmeasurable
levels of TNF-
, IFN-
, and NO following stimulation with parasite
antigen (Fig. 3B, E, and H, respectively). Nevertheless, anti-CD3
stimulation led to the production of low levels of all three mediators,
at equivalent levels in WT and IL-12
/
animals (Fig. 3B,
E, and H). The latter observation is consistent with the view that
IFN-
production during S. mansoni infection is IL-12
independent (30a). In cells from coinfected mice (Fig. 3C,
F, and I), the pattern of cytokine production was generally similar to
that seen for splenocytes from animals infected with T. gondii alone, although the levels of TNF-
and IFN-
produced by cells from WT mice that were not restimulated in vitro were lower
than was the case for cells from WT mice infected with T. gondii alone.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Proinflammatory mediator production is defective in
IL-12 / mice. TNF- (A through C), IFN- (D through
F), and NO (G through I) were measured in spleen cell culture
supernatants from S. mansoni (Sm), T. gondii
(Tg), or S. mansoni-plus-T. gondii-infected mice
euthanized 8 days after T. gondii infection. The cultures
were stimulated with SEA, STAg, or anti-CD3 MAb, and after 3 days,
supernatants were collected for cytokine and NO evaluation. Cytokines
were measured by ELISA and NO by Greiss reaction. The results are
representative of three separate experiments.
|
|
T. gondii infection in WT mice led to increased plasma
levels of TNF-
(Fig. 4A) and IFN-
(Fig. 4B). In dually infected mice, TNF-
levels increased even
further while IFN-
levels tended to be lower than those in mice
infected with T. gondii alone. In comparison, levels of
these cytokines were very low in the plasma of mice infected with
S. mansoni alone. Elevations in levels of TNF-
and
IFN-
were IL-12 dependent, since T. gondii- and S. mansoni-plus-T. gondii-infected IL-12
/
animals had plasma levels of these cytokines that were lower than in WT
animals. The difference in TNF-
production between double-infected
WT and IL-12
/
mice was statistically significant
(P < 0.05). However, the difference in IFN-
production between these two groups was not significant statistically
(P = 0.09).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
Elevated plasma levels of TNF- and IFN- are
dependent upon IL-12. Mice infected with S. mansoni (Sm),
T. gondii (Tg), or S. mansoni plus T. gondii were bled at 8 days post-T. gondii infection,
and ELISA was used to determine cytokine levels. The results are
expressed as means ± SD of three individual mice per group, and
the experiment was repeated three times with similar results. The
difference in TNF- production between dually infected WT and
IL-12 / mice was significant (P < 0.05).
|
|
To address the roles of TNF-
and NO in liver damage and death during
coinfection, we used TNFRp55
/
mice and WT mice treated
with aminoguanidine. Five mice were infected per group with S. mansoni plus T. gondii, and survival outcome was
assessed. Coinfected TNFRp55
/
mice and
aminoguanidine-treated mice survived a mean of 2 days longer than WT
coinfected controls (11.6 ± 1.5 versus 9.8 ± 0.4 days
[P = 0.0476] and 10.25 ± 0.96 versus 8.25 ± 0.5 days [P = 0.0433]), confirming a participation
for TNF-
and NO in the severe disease seen in coinfected mice.
IL-12
/
mice display increased resistance to
coinfection.
Correlating with their less severe liver damage,
dually infected IL-12
/
mice survived significantly
longer than did dually infected WT controls (mean ± standard
deviation [SD] time to death: 13.7 ± 1.5 versus 9.5 ± 0.7 days; P < 0.005 [Fig.
5]). Strikingly, the dually infected
IL-12
/
animals also exhibited prolonged time to death
relative to control IL-12-deficient mice infected with T. gondii alone (mean ± SD time to death: 13.7 ± 1.5 versus 10.5 ± 0.7 days; P < 0.005 [Fig. 5]).
As expected from previous reports (11),
IL-12
/
mice infected with T. gondii alone
died sooner than T. gondii-infected WT mice (Fig. 5).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
IL-12 / mice display increased resistance
to coinfection with S. mansoni and T. gondii
(Tg). As in other experiments, mice were infected percutaneously with
70 S. mansoni cercariae and then 7 weeks later were
administered an oral dose of 100 T. gondii cysts (ME49
strain). (A) Survival of IL-12 / mice infected with
T. gondii alone (open squares) or with S. mansoni
plus T. gondii (closed circles). (B) Survival of WT (open
circles) compared with IL-12 / (closed triangles) mice
coinfected with S. mansoni plus T. gondii. Five
mice were used in each group, and the experiments were repeated three
times. IL-12 / dually infected mice survived
significantly longer than both the IL-12 / mice infected
with T. gondii alone (P < 0.005) and the WT
coinfected mice (P < 0.005).
|
|
The role of reduced inflammatory mediator levels and of T. gondii burden in the prolonged survival of coinfected
IL-12
/
mice.
Because proinflammatory cytokines are
crucial for the control of T. gondii infection, it might be
predicted that the levels of IFN-
and TNF-
would be related to
parasite burden and to the outcome of infection in mice and moreover
that parasitemia would be directly correlated with disease severity.
However, compared to coinfected IL-12
/
mice, coinfected
WT animals produced higher levels of IFN-
, TNF-
, and NO (Fig. 3
and 4), and yet they died sooner (Fig. 5). Therefore, we examined
T. gondii levels in T. gondii- and S. mansoni-plus-T. gondii-infected WT and
IL-12
/
mice (Fig. 6). In
WT mice infected with T. gondii alone, SAG-2 transcripts
indicative of active T. gondii infection were present, and
in T. gondii- as well as S. mansoni-plus-T.
gondii-infected IL-12
/
mice, levels of SAG-2
appeared approximately twofold higher (as determined by scanning
densitometric analysis) (Fig. 6A). This result is consistent with the
reported inability of mice to control T. gondii infection in
the absence of IL-12 (11, 14, 15). It is interesting that
SAG-2 expression in WT coinfected mice appeared lower relative to that
in mice infected with T. gondii alone (Fig. 6A).

View larger version (113K):
[in this window]
[in a new window]
|
FIG. 6.
Liver T. gondii (Tg) burden in WT and
IL-12 / mice infected with T. gondii and
S. mansoni (Sm) plus T. gondii. (A) High levels
of SAG-2 transcripts (measured by RT-PCR amplification) were evident in
the livers of IL-12 / mice infected with T. gondii or with S. mansoni plus T. gondii.
Immunohistochemical staining of liver sections for T. gondii
showed low levels of T. gondii in single-infected WT (B) and
double-infected (C) animals, although in multiple sections there was a
trend toward fewer T. gondii foci in the coinfected group
(see text). Large numbers of T. gondii-positive foci were
evident in singly (D) and dually (E) infected IL-12 /
livers, although in the coinfected group fewer T. gondii-positive foci were evident (cf. D versus E). Control
sections from S. mansoni-infected mice were negative for
T. gondii staining. Original magnification, ×200. This
experiment was repeated twice with similar results.
|
|
T. gondii-specific immunohistochemical staining was
performed on liver sections from infected and control groups. As shown in Fig. 6, in T. gondii-infected WT mice (panel B), T. gondii levels were low relative to those in T. gondii-infected IL-12
/
mice (panel D) (0.3 ± 0.6 versus 68 ± 23 parasite foci per field for WT and
IL-12
/
, respectively; P = 0.01). In WT
coinfected animals, we counted 2.3 ± 1.5 parasite foci per field
(Fig. 6C), compared with 23 ± 6 (Fig. 6E) in
IL-12
/
mice carrying a dual infection (P < 0.005). Two conclusions can be drawn from these data. First, as
anticipated, T. gondii parasitemia is controlled by IL-12.
Second, the immunohistochemical stain suggests that S. mansoni may confer some resistance to T. gondii (panels
D and E).
T. gondii induces an IL-12-dependent suppression of
S. mansoni-induced type 2 cytokine responses.
Severe
disease in dually infected mice could be due not only to exacerbated
inflammatory cytokine production but also to suppression of the
anti-inflammatory S. mansoni-specific Th2 response that is
important for survival with S. mansoni alone
(8). To examine this, we assessed production of the
signature type 2 cytokines IL-5 and IL-10 in single and double
infections in WT and IL-12
/
mice. Because these
cytokines could not be detected in the plasma (data not shown), we
examined production in antigen- and anti-CD3-stimulated splenocyte
cultures. In no case could we detect IL-5 by using cells from mice
infected with T. gondii alone, although cells from these
animals did make IL-10 but only in response to anti-CD3 (data not
shown). However, cells from WT mice infected with S. mansoni
produced high levels of IL-5 and IL-10 in response to SEA and anti-CD3
but not to STAg. Splenocytes from S. mansoni-infected IL-12
/
animals made similar levels of IL-5 to those
produced by WT mice, but it is interesting that they failed to make
IL-10 in response to antigen, although anti-CD3-driven responses
appeared intact (Fig. 7A and C).
Superinfection of S. mansoni-infected WT mice with T. gondii led to a suppression of IL-5 and IL-10 production (cf. Fig.
7A and C versus B and D); this suppression is mediated at least in part
by endogenous IL-12 production since dually infected IL-12
/
mice had no defect in their ability to make IL-5
(Fig. 7B) in response to antigen or anti-CD3 or to make IL-10 after
stimulation with anti-CD3 (Fig. 7D). Similar results were found when
IL-4 was measured (data not shown).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 7.
T. gondii (Tg) infection suppresses IL-5 and
IL-10 production in S. mansoni (Sm)-infected mice in an
IL-12-dependent manner. IL-5 and IL-10 in supernatants of spleen cells
stimulated with SEA, STAg, or anti-CD3 for 3 days were measured by
ELISA. (A and C) Mice infected with S. mansoni; (B and D)
mice infected with S. mansoni plus T. gondii.
IL-5 levels are shown in A and B, and IL-10 levels are shown in C and
D. The experiment was performed twice with similar results.
|
|
 |
DISCUSSION |
C57BL/6 mice infected with S. mansoni are acutely
susceptible to peroral infection with T. gondii
(23). Disease due to dual infection is characterized by
precipitous weight loss followed by death, with severe liver damage
implicated as the cause (23). We have hypothesized that,
during schistosomiasis, the liver is acutely sensitive to the high
levels of inflammatory mediators that are produced in response to
T. gondii infection. Support for this idea is provided by
the prior observations that (i) S. mansoni-infected mice,
like D-gal-primed animals, succumb to liver failure
when challenged with low doses of endotoxin (13, 20, 28) and (ii) T. gondii extract behaves like endotoxin
inasmuch as it causes lethal liver failure in
D-gal-sensitized mice (24). In this report we
have used IL-12
/
mice to directly examine the role of
proinflammatory mediator production in the severe disease that
accompanies dual infection. Compared to coinfected WT mice, coinfected
IL-12-deficient animals had reduced levels of IFN-
, TNF-
, and NO,
elevated Th2 responses, and diminished liver disease. Consistent with
the view that, during concurrent infection, IL-12 promotes the
production of life-threatening levels of inflammatory mediators, dually
infected IL-12
/
mice survived significantly longer than
dually infected WT animals. In contrast, IL-12
/
mice
infected with T. gondii alone died before T. gondii-infected WT mice (data not shown), confirming the
underlying importance of IL-12 in survival against this intracellular
infection. As was expected from a host compromised in its ability to
mount a Th1-like response, dually infected IL-12
/
mice
had more T. gondii within their livers than did dually
infected WT mice. However, at least by immunohistochemical staining,
the coinfected IL-12-deficient mice appeared to have a lower hepatic T. gondii burden than did single-parasite-infected
IL-12
/
mice, suggesting that an IL-12-independent
S. mansoni-induced mechanism of temporarily controlling
T. gondii growth may exist. Thus prolonged survival in
coinfected IL-12
/
mice may be due to diminished
inflammatory mediator production combined with a reduced parasite burden.
Comparing WT and IL-12
/
mice infected with S. mansoni alone, the absence of IL-12 has little or no effect on
major measures of morbidity such as weight loss or increased mortality
(data not shown), although plasma AST levels were lower in the
IL-12
/
animals, raising the possibility of an
underlying role for IL-12 in tissue damage during schistosomiasis.
Consistent with previous findings (30a), measured immune
responses revealed no differences between schistosome-infected
IL-12
/
mice and schistosome-infected WT mice. The
situation was quite different during T. gondii infection,
however, when, as previously described, IL-12
/
mice
rapidly succumbed to infection. This increased susceptibility is
accompanied by significantly increased parasitemia and decreased production of inflammatory mediators in vivo and in vitro. The most
straightforward interpretation of these data is that, in WT mice, IL-12
plays the pivotal role in promoting Th1 response development and that
without amplification of the production of inflammatory mediators such
as IFN-
, TNF-
, and NO, parasite replication proceeds in an
uncontrolled fashion, and the host dies of direct cellular damage
occurring as a result of this process. Death in the WT mice that
succumb after exposure to T. gondii appears to have a
different cause, since in these animals liver parasite burdens were
very low. Previous reports (22) have indicated that the
CD4 cell- and IFN-
-dependent intestinal immunopathology contributes
to morbidity and death in these mice.
The differences between single-infected and dually infected WT mice
were as previously described (23), in that infection with
S. mansoni rendered WT mice acutely sensitive to T. gondii infection. On the basis of our data, we argued previously
(23) that this increase in disease severity due to dual
infection was the result of T. gondii-induced
TNF-
-mediated severe damage to a liver already inflamed as a result
of the granulomatous response to schistosome eggs trapped in the
sinusoids. New data presented here indicate that T. gondii
infection also leads to suppression of the S. mansoni-induced Th2 response. This latest observation raises the
possibility that the exacerbated disease in dually infected mice may be
in part the result of a diminished Th2 response to S. mansoni, a condition that mimics that seen in infected
IL-4
/
mice, in which S. mansoni infection
alone is lethal (8). Consistent with this hypothesis,
morbidity was reduced and mortality delayed when
proinflammatory-mediator production was suppressed as a result of IL-12
gene deletion and, to a lesser extent, when inflammatory signaling by
TNF-
was decreased through TNFRp55 deletion and when NO production
was inhibited. The absence of IL-12 resulted in greatly diminished
IFN-
and TNF-
production in dually infected mice. Additionally,
the suppression of Th2 responses observed in dually infected WT mice
was partially reversed in the absence of IL-12, raising the possibility
that, through the production of regulatory mediators such as IL-10, the
schistosome-induced Th2 response could be playing a role in
IL-12
/
mice in further controlling inflammation
associated with the T. gondii infection.
Increased survival time in coinfected IL-12
/
mice was
accompanied by less severe liver damage as assessed microscopically and by plasma levels of AST. Lesions in the livers of coinfected WT mice
were largely as described previously (23): extensive
granulomatous inflammation surrounding schistosome eggs, accompanied by
excessive damage in the liver parenchyma, where hepatocytes were
vacuolated, and in which large areas of coagulation necrosis were
apparent. Additionally, the granulomas around schistosome eggs were
smaller in double-infected mice than those in mice infected with
S. mansoni alone, as previously demonstrated
(23). None of these effects were evident in the dually
infected IL-12
/
mice, which had liver changes that were
histologically similar to those seen in S. mansoni-infected
WT mice. These data argue strongly that the enhanced, novel liver
damage observed in dual-infected WT mice is entirely the result of an
IL-12-driven immunopathologic process. Consistent with this theme, a
role for IL-12 in promoting hepatic immunopathology in Leishmania
donovani infection has been recently reported (32).
The suppression of Th2 responses that accompanies T. gondii
infection in S. mansoni-infected mice is a previously
unrecognized aspect of dual infection. Previously we examined IgE
levels in coinfected mice, but we found little evidence for a decrease
in levels of this IL-4-dependent isotype (23). However,
given the short duration of T. gondii infection
(approximately 8 days) and the half-life of the antibody, this is
perhaps not surprising. In the present study we focused on Th2 cytokine
production by T cells from dually infected mice and noted that IL-5 and
IL-10 levels were depressed compared to those produced by cells from mice infected with S. mansoni alone; this suppression is
mediated by a process that is IL-12 dependent, since it is not apparent in dually infected IL-12
/
animals. The mechanism by
which T. gondii-induced IL-12 down-regulates the S. mansoni-induced Th2 response is unclear.
The inference of these studies is that, during schistosomiasis, the
liver is acutely sensitive to inflammatory mediators associated with a
Th1 response. Studies using IL-4
/
(8),
IL-4/IL-10
/
(19), and
IL-4/IL-13
/
(12) mice, which mount Th1
rather than Th2 responses during S. mansoni infection and
develop lethal wasting disease, strongly support the view that type-1
responses can be deleterious during schistosomiasis. We have argued
that the primary function of the Th2 response that normally develops
during S. mansoni infection is to limit Th1-like
inflammatory responses while simultaneously sequestering parasite eggs
away from the surrounding liver tissue (7). Data presented
show that mice infected with S. mansoni are susceptible to
IL-12-mediated inflammatory responses even when they are already
mounting a strong Th2 response. These data suggest that the use of
IL-12 to promote antifibrotic Th1 responses and thereby minimize liver
damage in schistosomiasis may not be risk free (9, 33,
39).
Given the prevalence of T. gondii infection in areas with
endemic schistosomiasis, it seems likely that individuals are
simultaneously afflicted with both diseases, although to the best of
our knowledge this has not been directly investigated. Our current
studies are directed towards determining the frequency of
seropositivity for T. gondii in areas where it is endemic
versus areas where it is nonendemic with a view to examining the
relevance of the experimental data presented here to the clinical
situation in areas of endemicity.
 |
ACKNOWLEDGMENTS |
This work was supported by NIH grants AI32573 to E.J.P. and
AI40540 to E.Y.D. M.I.A. is supported by D43 TW00919 International Training and Research in Emerging Infectious Diseases. Schistosome life
cycle stages for this work were provided under NIH-NIAID contract
NO1-AI-55270.
We thank Edgar Carvalho and Warren Johnson for their support, Beverley
Bauman for technical assistance, and Andrew MacDonald, Anne LaFlamme,
and Elisabeth Patton for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401. Phone: (607) 253-4022. Fax: (607)
253-3384. E-mail: eyd1{at}cornell.edu.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Abbas, A. K.,
K. M. Murphy, and A. Sher.
1996.
Functional diversity of helper T lymphocytes.
Nature
383:787-793[CrossRef][Medline].
|
| 2.
|
Alexander, J., and C. A. Hunter.
1998.
Immunoregulation during toxoplasmosis.
Chem. Immunol.
70:81-102[Medline].
|
| 3.
|
Araujo, M. I.,
A. R. de Jesus,
O. Bacellar,
E. Sabin,
E. Pearce, and E. M. Carvalho.
1996.
Evidence of a T helper type 2 activation in human schistosomiasis.
Eur. J. Immunol.
26:1399-1403[Medline].
|
| 4.
|
Bliss, S. K.,
Y. Zhang, and E. Y. Denkers.
1999.
Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-gamma-independent IL-12.
J. Immunol.
163:2081-2088[Abstract/Free Full Text].
|
| 5.
|
Boros, D. L., and M. A. Lande.
1983.
Induction of collagen synthesis in cultured human fibroblasts by live Schistosoma mansoni eggs and soluble egg antigens (SEA).
Am. J. Trop. Med. Hyg.
32:78-82.
|
| 6.
|
Boros, D. L.,
R. Tomford, and K. S. Warren.
1977.
Induction of granulomatous and elicitation of cutaneous sensitivity by partially purified SEA of Schistosoma mansoni.
J. Immunol.
118:373-376[Abstract/Free Full Text].
|
| 7.
|
Brunet, L. R.,
M. Beall,
D. W. Dunne, and E. J. Pearce.
1999.
Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection.
J. Immunol.
163:4976-4984[Abstract/Free Full Text].
|
| 8.
|
Brunet, L. R.,
F. D. Finkelman,
A. W. Cheever,
M. A. Kopf, and E. J. Pearce.
1997.
IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis.
J. Immunol.
159:777-785[Abstract].
|
| 9.
|
Cheever, A. W.,
D. Jankovic,
G. S. Yap,
M. C. Kullberg,
A. Sher, and T. A. Wynn.
1998.
Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice.
Mem. Inst. Oswaldo Cruz
93:25-32.
|
| 10.
|
Denkers, E. Y.
1999.
T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii.
Microbes Infect.
1:699-708[CrossRef][Medline].
|
| 11.
|
Ely, K. H.,
L. H. Kasper, and I. A. Khan.
1999.
Augmentation of the CD8+ T cell response by IFN-gamma in IL-12-deficient mice during Toxoplasma gondii infection.
J. Immunol.
162:5449-5454[Abstract/Free Full Text].
|
| 12.
|
Fallon, P. G.,
E. J. Richardson,
G. J. McKenzie, and A. N. McKenzie.
2000.
Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.
J. Immunol.
164:2585-2591[Abstract/Free Full Text].
|
| 13.
|
Galanos, C.,
M. A. Freudenberg, and W. Reutter.
1979.
Galactosamine-induced sensitization to the lethal effects of endotoxin.
Proc. Natl. Acad. Sci. USA
76:5939-5943[Abstract/Free Full Text].
|
| 14.
|
Gazzinelli, R. T.,
S. Hayashi,
M. Wysocka,
L. Carrera,
R. Kuhn,
W. Muller,
F. Roberge,
G. Trinchieri, and A. Sher.
1994.
Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide.
J. Eukaryot. Microbiol.
41:9S[Medline].
|
| 15.
|
Gazzinelli, R. T.,
M. Wysocka,
S. Hayashi,
E. Y. Denkers,
S. Hieny,
P. Caspar,
G. Trinchieri, and A. Sher.
1994.
Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.
J. Immunol.
153:2533-2543[Abstract].
|
| 16.
|
Gazzinelli, R. T.,
M. Wysocka,
S. Hieny,
T. Scharton-Kersten,
A. Cheever,
R. Kuhn,
W. Muller,
G. Trinchieri, and A. Sher.
1996.
In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
J. Immunol.
157:798-805[Abstract].
|
| 17.
|
Grzych, J. M.,
E. Pearce,
A. Cheever,
Z. A. Caulada,
P. Caspar,
S. Heiny,
F. Lewis, and A. Sher.
1991.
Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni.
J. Immunol.
146:1322-1327[Abstract].
|
| 18.
|
Himmelrich, H.,
C. Parra-Lopez,
F. Tacchini-Cottier,
J. A. Louis, and P. Launois.
1998.
The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
J. Immunol.
161:6156-6163[Abstract/Free Full Text].
|
| 19.
|
Hoffmann, K. F.,
S. L. James,
A. W. Cheever, and T. A. Wynn.
1999.
Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
J. Immunol.
163:927-938[Abstract/Free Full Text].
|
| 20.
|
Lehmann, V.,
M. A. Freudenberg, and C. Galanos.
1987.
Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.
J. Exp. Med.
165:657-663[Abstract/Free Full Text].
|
| 21.
|
Liesenfeld, O.,
H. Kang,
D. Park,
T. A. Nguyen,
C. V. Parkhe,
H. Watanabe,
T. Abo,
A. Sher,
J. S. Remington, and Y. Suzuki.
1999.
TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii.
Parasite Immunol.
21:365-376[CrossRef][Medline].
|
| 22.
|
Liesenfeld, O.,
J. Kosek,
J. S. Remington, and Y. Suzuki.
1996.
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii.
J. Exp. Med.
184:597-607[Abstract/Free Full Text].
|
| 23.
|
Marshall, A. J.,
L. R. Brunet,
Y. van Gessel,
A. Alcaraz,
S. K. Bliss,
E. J. Pearce, and E. Y. Denkers.
1999.
Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice.
J. Immunol.
163:2089-2097[Abstract/Free Full Text].
|
| 24.
|
Marshall, A. J., and E. Y. Denkers.
1998.
Toxoplasma gondii triggers granulocyte-dependent cytokine-mediated lethal shock in D-galactosamine-sensitized mice.
Infect. Immun.
66:1325-1333[Abstract/Free Full Text].
|
| 25.
|
Mosmann, T. R.,
H. Cherwinski,
M. W. Bond,
M. A. Giedlin, and R. L. Coffman.
1986.
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
J. Immunol.
136:2348-2357[Abstract].
|
| 26.
|
Mountford, A. P.,
P. S. Coulson,
A. W. Cheever,
A. Sher,
R. A. Wilson, and T. A. Wynn.
1999.
Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses.
Immunology
97:588-594[CrossRef][Medline].
|
| 27.
|
Mwatha, J. K.,
G. Kimani,
T. Kamau,
G. G. Mbugua,
J. H. Ouma,
J. Mumo,
A. J. Fulford,
F. M. Jones,
A. E. Butterworth,
M. B. Roberts, and D. W. Dunne.
1998.
High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.
J. Immunol.
160:1992-1999[Abstract/Free Full Text].
|
| 28.
|
Nagaki, M.,
Y. Muto,
H. Ohnishi,
S. Yasuda,
K. Sano,
T. Naito,
T. Maeda,
T. Yamada, and H. Moriwaki.
1994.
Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B.
Gastroenterology
106:450-458[Medline].
|
| 29.
|
Neyer, L. E.,
G. Grunig,
M. Fort,
J. S. Remington,
D. Rennick, and C. A. Hunter.
1997.
Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii.
Infect. Immun.
65:1675-1682[Abstract].
|
| 30.
|
Paludan, S. R.
1998.
Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship.
Scand. J. Immunol.
48:459-468[CrossRef][Medline].
|
| 30a.
|
Patton, E. A.,
L. R. Brunet,
A. C. La Flamme,
J. Pedras-Vasconcelos,
M. Kopf, and E. J. Pearce.
2001.
Severe schistosomiasis in the absence of interleukin-4 (IL-4) is IL-12 independent.
Infect. Immun.
69:589-592[Abstract/Free Full Text].
|
| 31.
|
Pearce, E. J.,
P. Caspar,
J. M. Grzych,
F. A. Lewis, and A. Sher.
1991.
Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.
J. Exp. Med.
173:159-166[Abstract/Free Full Text].
|
| 32.
|
Satoskar, A. R.,
S. Rodig,
S. R. Telford III,
A. A. Satoskar,
S. K. Ghosh,
F. von Lichtenberg, and J. R. David.
2000.
IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Eur. J. Immunol.
30:834-839[CrossRef][Medline].
|
| 33.
|
Sher, A.,
D. Jankovic,
A. Cheever, and T. Wynn.
1996.
An IL-12-based vaccine approach for preventing immunopathology in schistosomiasis.
Ann. N. Y. Acad. Sci.
795:202-207[CrossRef][Medline].
|
| 34.
|
Suzuki, Y.,
M. A. Orellana,
R. D. Schreiber, and J. S. Remington.
1988.
Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.
Science
240:516-518[Abstract/Free Full Text].
|
| 35.
|
Suzuki, Y.,
Q. Yang,
F. K. Conley,
J. S. Abrams, and J. S. Remington.
1994.
Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis.
Infect. Immun.
62:2773-2778[Abstract/Free Full Text].
|
| 36.
|
Szabo, S. J.,
A. S. Dighe,
U. Gubler, and K. M. Murphy.
1997.
Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells.
J. Exp. Med.
185:817-824[Abstract/Free Full Text].
|
| 37.
|
Williams, M. E.,
S. Montenegro,
A. L. Domingues,
T. A. Wynn,
K. Teixeira,
S. Mahanty,
A. Coutinho, and A. Sher.
1994.
Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens.
J. Infect. Dis.
170:946-954[Medline].
|
| 38.
|
Wu, C. Y.,
M. Gadina,
K. Wang,
J. O'Shea, and R. A. Seder.
2000.
Cytokine regulation of IL-12 receptor beta2 expression: differential effects on human T and NK cells.
Eur. J. Immunol.
30:1364-1374[CrossRef][Medline].
|
| 39.
|
Wynn, T. A.,
A. W. Cheever,
D. Jankovic,
R. W. Poindexter,
P. Caspar,
F. A. Lewis, and A. Sher.
1995.
An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection.
Nature
376:594-596[CrossRef][Medline].
|
Infection and Immunity, March 2001, p. 1454-1462, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1454-1462.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bazzone, L. E., Smith, P. M., Rutitzky, L. I., Shainheit, M. G., Urban, J. F., Setiawan, T., Blum, A. M., Weinstock, J. V., Stadecker, M. J.
(2008). Coinfection with the Intestinal Nematode Heligmosomoides polygyrus Markedly Reduces Hepatic Egg-Induced Immunopathology and Proinflammatory Cytokines in Mouse Models of Severe Schistosomiasis. Infect. Immun.
76: 5164-5172
[Abstract]
[Full Text]
-
Frantz, F. G., Rosada, R. S., Turato, W. M., Peres, C. M., Coelho-Castelo, A. A. M., Ramos, S. G., Aronoff, D. M., Silva, C. L., Faccioli, L. H.
(2007). The Immune Response to Toxocariasis Does Not Modify Susceptibility to Mycobacterium tuberculosis Infection in BALB/c Mice. Am J Trop Med Hyg
77: 691-698
[Abstract]
[Full Text]
-
Weng, M., Huntley, D., Huang, I-F., Foye-Jackson, O., Wang, L., Sarkissian, A., Zhou, Q., Walker, W. A., Cherayil, B. J., Shi, H. N.
(2007). Alternatively Activated Macrophages in Intestinal Helminth Infection: Effects on Concurrent Bacterial Colitis. J. Immunol.
179: 4721-4731
[Abstract]
[Full Text]
-
Chen, C.-C., Louie, S., McCormick, B., Walker, W. A., Shi, H. N.
(2005). Concurrent Infection with an Intestinal Helminth Parasite Impairs Host Resistance to Enteric Citrobacter rodentium and Enhances Citrobacter-Induced Colitis in Mice. Infect. Immun.
73: 5468-5481
[Abstract]
[Full Text]
-
Kane, C. M., Cervi, L., Sun, J., McKee, A. S., Masek, K. S., Shapira, S., Hunter, C. A., Pearce, E. J.
(2004). Helminth Antigens Modulate TLR-Initiated Dendritic Cell Activation. J. Immunol.
173: 7454-7461
[Abstract]
[Full Text]
-
Liesenfeld, O., Dunay, I. R., Erb, K. J.
(2004). Infection with Toxoplasma gondii Reduces Established and Developing Th2 Responses Induced by Nippostrongylus brasiliensis Infection. Infect. Immun.
72: 3812-3822
[Abstract]
[Full Text]
-
Nguyen, T. D., Bigaignon, G., Markine-Goriaynoff, D., Heremans, H., Nguyen, T. N., Warnier, G., Delmee, M., Warny, M., Wolf, S. F., Uyttenhove, C., Van Snick, J., Coutelier, J. -P.
(2003). Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and {gamma}-interferon. J Med Microbiol
52: 869-876
[Abstract]
[Full Text]
-
Rutitzky, L. I., Hernandez, H. J., Stadecker, M. J.
(2001). Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc. Natl. Acad. Sci. USA
10.1073/pnas.231258498v1
[Abstract]
[Full Text]
-
Rutitzky, L. I., Hernandez, H. J., Stadecker, M. J.
(2001). Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc. Natl. Acad. Sci. USA
98: 13243-13248
[Abstract]
[Full Text]